Sphingolipids in High Fat Diet and Obesity-Related Diseases

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2015 Dec 10

PMID 26648664

Citations 64

Authors

Songhwa Choi

Ashley J Snider

Affiliations

Soon will be listed here.

Abstract

Nutrient oversupply associated with a high fat diet (HFD) significantly alters cellular metabolism, and specifically including sphingolipid metabolism. Sphingolipids are emerging as bioactive lipids that play key roles in regulating functions, in addition to their traditional roles as membrane structure. HFD enhances de novo sphingolipid synthesis and turnover of sphingolipids via the salvage pathway, resulting in the generation of ceramide, and more specifically long chain ceramide species. Additionally, HFD elevates sphingomyelin and sphingosine-1 phosphate (S1P) levels in several tissues including liver, skeletal muscle, adipose tissue, and cardiovascular tissues. HFD-stimulated sphingolipid generation contributes to systemic insulin resistance, dysregulated lipid accumulation, and cytokine expression and secretion from skeletal muscle and adipose tissues, exacerbating obesity-related conditions. Furthermore, altered sphingolipid levels, particularly ceramide and sphingomyelin, are involved in obesity-induced endothelial dysfunction and atherosclerosis. In this review, HFD-mediated sphingolipid metabolism and its impact on HFD-induced biology and pathobiology will be discussed.

Citing Articles

Sphingolipids and Chronic Kidney Disease.

Sakic Z, Atic A, Potocki S, Basic-Jukic N J Clin Med. 2024; 13(17).

PMID: 39274263 PMC: 11396415. DOI: 10.3390/jcm13175050.

Ceramide microdomains: the major influencers of the sphingolipid media platform.

Weber-Stout M, Nicholson R, Dumaguit C, Holland W, Summers S Biochem Soc Trans. 2024; 52(4):1765-1776.

PMID: 39082976 PMC: 11845337. DOI: 10.1042/BST20231395.

Ceramides as Emerging Players in Cardiovascular Disease: Focus on Their Pathogenetic Effects and Regulation by Diet.

Spaggiari R, Angelini S, Di Vincenzo A, Scaglione G, Morrone S, Finello V Adv Nutr. 2024; 15(7):100252.

PMID: 38876397 PMC: 11263787. DOI: 10.1016/j.advnut.2024.100252.

Vasodilator reactive oxygen species ameliorate perturbed myocardial oxygen delivery in exercising swine with multiple comorbidities.

van Drie R, van de Wouw J, Zandbergen L, Dehairs J, Swinnen J, Mulder M Basic Res Cardiol. 2024; 119(5):869-887.

PMID: 38796544 PMC: 11461570. DOI: 10.1007/s00395-024-01055-z.

Untargeted metabolomics based on ultra-high performance liquid chromatography-mass spectrometry/MS reveals the lipid-lowering mechanism of taurine in hyperlipidemia mice.

Guo X, Ou T, Yang X, Song Q, Zhu L, Mi S Front Nutr. 2024; 11:1367589.

PMID: 38706565 PMC: 11066166. DOI: 10.3389/fnut.2024.1367589.

References

Chavez J, Siddique M, Wang S, Ching J, Shayman J, Summers S . Ceramides and glucosylceramides are independent antagonists of insulin signaling. J Biol Chem. 2013; 289(2):723-34. PMC: 3887200. DOI: 10.1074/jbc.M113.522847. View

Glaros E, Kim W, Rye K, Shayman J, Garner B . Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice. J Lipid Res. 2008; 49(8):1677-81. DOI: 10.1194/jlr.E800005-JLR200. View

Holland W, Bikman B, Wang L, Yuguang G, Sargent K, Bulchand S . Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest. 2011; 121(5):1858-70. PMC: 3083776. DOI: 10.1172/JCI43378. View

Ouchi N, Parker J, Lugus J, Walsh K . Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2):85-97. PMC: 3518031. DOI: 10.1038/nri2921. View

Kowalski G, Carey A, Selathurai A, Kingwell B, Bruce C . Plasma sphingosine-1-phosphate is elevated in obesity. PLoS One. 2013; 8(9):e72449. PMC: 3765451. DOI: 10.1371/journal.pone.0072449. View

Turpin S, Nicholls H, Willmes D, Mourier A, Brodesser S, Wunderlich C . Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 2014; 20(4):678-86. DOI: 10.1016/j.cmet.2014.08.002. View

Shah C, Yang G, Lee I, Bielawski J, Hannun Y, Samad F . Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem. 2008; 283(20):13538-48. PMC: 2376236. DOI: 10.1074/jbc.M709950200. View

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

Liu Y, Turdi S, Park T, Morris N, Deshaies Y, Xu A . Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis. Diabetes. 2012; 62(3):743-52. PMC: 3581202. DOI: 10.2337/db12-0687. View

10.

Park T, Panek R, Mueller S, Hanselman J, Rosebury W, Robertson A . Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2004; 110(22):3465-71. DOI: 10.1161/01.CIR.0000148370.60535.22. View

11.

Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T . Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med. 1996; 2(7):800-3. DOI: 10.1038/nm0796-800. View

12.

Powell D, Turban S, Gray A, Hajduch E, Hundal H . Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J. 2004; 382(Pt 2):619-29. PMC: 1133819. DOI: 10.1042/BJ20040139. View

13.

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

14.

Chakraborty M, Lou C, Huan C, Kuo M, Park T, Cao G . Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis. J Clin Invest. 2013; 123(4):1784-97. PMC: 3613902. DOI: 10.1172/JCI60415. View

15.

Garner B, Mellor H, Butters T, Dwek R, Platt F . Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids. Biochem Biophys Res Commun. 2002; 290(5):1361-7. DOI: 10.1006/bbrc.2002.6356. View

16.

Hashimoto T, Igarashi J, Kosaka H . Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesis. J Lipid Res. 2008; 50(4):602-10. PMC: 2656653. DOI: 10.1194/jlr.M800206-JLR200. View

17.

Brozinick J, Hawkins E, Hoang Bui H, Kuo M, Tan B, Kievit P . Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet. Int J Obes (Lond). 2012; 37(8):1064-70. PMC: 3718866. DOI: 10.1038/ijo.2012.191. View

18.

Cinar R, Godlewski G, Liu J, Tam J, Jourdan T, Mukhopadhyay B . Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides. Hepatology. 2013; 59(1):143-53. PMC: 3839256. DOI: 10.1002/hep.26606. View

19.

Mehra V, Jackson E, Zhang X, Jiang X, Dobrucki L, Yu J . Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis. Am J Pathol. 2014; 184(5):1562-76. PMC: 4005977. DOI: 10.1016/j.ajpath.2014.01.009. View

20.

Okuwa H, Kanno T, Fujita Y, Gotoh A, Tabata C, Fukuoka K . Sphingosine suppresses mesothelioma cell proliferation by inhibiting PKC-δ and inducing cell cycle arrest at the G(0)/G(1) phase. Cell Physiol Biochem. 2012; 30(4):995-1004. DOI: 10.1159/000341476. View